KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Evolent Health (EVH) over the last 12 years, with Q3 2025 value amounting to 0.34.

  • Evolent Health's Equity Ratio fell 1731.71% to 0.34 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.34, marking a year-over-year decrease of 1731.71%. This contributed to the annual value of 0.39 for FY2024, which is 121.43% down from last year.
  • Latest data reveals that Evolent Health reported Equity Ratio of 0.34 as of Q3 2025, which was down 1731.71% from 0.36 recorded in Q2 2025.
  • Evolent Health's Equity Ratio's 5-year high stood at 0.49 during Q4 2021, with a 5-year trough of 0.34 in Q3 2025.
  • Its 5-year average for Equity Ratio is 0.43, with a median of 0.43 in 2024.
  • The largest annual percentage gain for Evolent Health's Equity Ratio in the last 5 years was 818.2% (2021), contrasted with its biggest fall of 1902.27% (2021).
  • Evolent Health's Equity Ratio (Quarter) stood at 0.49 in 2021, then decreased by 3.22% to 0.47 in 2022, then dropped by 15.77% to 0.4 in 2023, then dropped by 1.21% to 0.39 in 2024, then decreased by 12.76% to 0.34 in 2025.
  • Its Equity Ratio was 0.34 in Q3 2025, compared to 0.36 in Q2 2025 and 0.35 in Q1 2025.